Find Me Cure

SEPTEMBER 2, 2020

As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .

Clinical Research 97

Clinical Research Research Clinical Trials Clinical Trials 97

pharmaphorum

JANUARY 24, 2022

. “The cost of developing a new drug is extortionately high,” said Landray, adding that a very large proportion of those costs is in phase 3, and that means many promising therapies may never be taken forward by pharma companies.

Trials 88

Trials Drugs Clinical Trials Clinical Trials 88

pharmaphorum

DECEMBER 21, 2021

Additionally, the work being done within Rare Disease networks, formed of specialty sites, pharma companies, CROs, researchers, and other stakeholders, can all benefit from the value generated by real world genomic data, as outlined by panellist Dr Joanne Hackett, Head of Genomic and Precision medicine at IQVIA.

Development 96

Development Genome Genomics Drugs 96

pharmaphorum

MARCH 12, 2021

That was the message from ‘The New Normal: Balancing the rapid evolution of trial design with patient need’ panel at the NIHR’s Clinical Research Network Virtual Event on Delivering Complex and Innovative Design (CID) Studies. Thankfully, many pharma companies seem to be gradually improving on this. Listening to patients.

Trials 124

Trials Research Pharma Companies Clinical Trials 124

pharmaphorum

SEPTEMBER 1, 2020

Another military man in the drugs business was Edward Robinson Squibb, who as a naval doctor during the Mexican-American war of 1846–1848 threw the drugs he was supplied with overboard due to their low quality. Thalidomide and the development of drug safety regulation and monitoring. George Merck on the cover of Time magazine.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

XTalks

OCTOBER 1, 2020

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. In the beginning, I always thought I wanted to be a doctor, but then I felt it was very depressing, particularly at that time and in that particular field.

Scientist 52

Scientist In-Vitro Research Life Science 52